These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 196858)

  • 1. Hemodynamic studies of beta blockade in hypertrophic obstructive cardiomyopathy.
    Swanton RH; Brooksby IA; Jenkins BS; Webb-Peploe MM
    Eur J Cardiol; 1977 Jun; 5(4):327-41. PubMed ID: 196858
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemodynamic effects of propranolol on obstructive myocardiopathy].
    Ourbak P; Bourdarias JP; Cachin JC; Rocha P; Scebat L; Lenègre J
    Arch Mal Coeur Vaiss; 1971 Mar; 64(3):352-71. PubMed ID: 4397007
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of selective beta adrenergic block on myocardial contractility. Relative role of negative inotropic and chronotropic effects].
    Bardet J; Rigaud M; Rocha P; Bourdarias JP; Mathivat A
    Arch Mal Coeur Vaiss; 1974 Oct; 67(10):1169-79. PubMed ID: 4218730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy.
    Rosing DR; Kent KM; Maron BJ; Condit J; Epstein SE
    Clin Invest Med; 1980; 3(1-2):195-203. PubMed ID: 7009000
    [No Abstract]   [Full Text] [Related]  

  • 5. Integrated response to exercise in patients with hypertrophic obstructive cardiomyopathy and effect of beta-adrenergic blockade on oxygen transport.
    Edwards RH; Kristinsson A; Warrell DA
    Br Heart J; 1969 May; 31(3):390. PubMed ID: 4396140
    [No Abstract]   [Full Text] [Related]  

  • 6. Demonstration of two different types of beta1-receptors in man (selective blockade of the positively inotropic and the positively chronotropic effect of isoproterenol).
    Bonelli J
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):313-9. PubMed ID: 208993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alternations of cardiac performance in the avoluations of obstructive cardiomyopathy. Prognostic significance (author's transl)].
    Emeriau JP; Besse P; Sicart M; Conri C; Martin P; Bricaud H
    Ann Radiol (Paris); 1977; 20(3-4):371-8. PubMed ID: 560159
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative studies on propranolol and practolol].
    Bodem G; Chidsey CA
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1662-3. PubMed ID: 4150007
    [No Abstract]   [Full Text] [Related]  

  • 9. A model for distinguishing between beta1-receptors which mediate a specific effect on the heart rate and those which mediate a positively inotropic effect.
    Bonelli J; Magometschnigg D; Hitzenberger G; Kaik G
    Int J Clin Pharmacol Biopharm; 1977 Aug; 15(8):381-3. PubMed ID: 19365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind trial of propranolol and practolol in hypertrophic cardiomyopathy.
    Hubner PJ; Ziady GM; Lane GK; Hardarson T; Scales B; Oakley CM; Goodwin JF
    Br Heart J; 1973 Nov; 35(11):1116-23. PubMed ID: 4586631
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemodynamic long-term results after medical and surgical therapy of hypertrophic cardiomyopathies.
    Lösse B; Loogen F; Schulte HD
    Z Kardiol; 1987; 76 Suppl 3():119-30. PubMed ID: 3433864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inosine as a cardiotonic agent that reverses adrenergic beta blockade.
    Juhász-Nagy A; Aviado DM
    J Pharmacol Exp Ther; 1977 Sep; 202(3):683-95. PubMed ID: 197230
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypertrophic occlusive cardiomyopathy.
    Kaltenbach M; Hopf R
    Clin Invest Med; 1980; 3(1-2):179-84. PubMed ID: 7008998
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemodynamics in patients suffering from hyperkinetic cardiac syndromes and in normal persons under psychological stress before and after treatment with propranolol (author's transl)].
    Magometschnigg D; Bonelli J; Kaik G
    Z Kardiol; 1979 Mar; 68(3):183-8. PubMed ID: 220809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol.
    Bodem G; Brammell HL; Weil JV; Chidsey CA
    J Clin Invest; 1973 Apr; 52(4):747-54. PubMed ID: 4144332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and hemodynamic effects of verapamil in hypertrophic obstructive cardiomyopathy].
    Lösse B; Kuhn H; Loogen F
    Z Kardiol; 1982 Dec; 71(12):813-9. PubMed ID: 6891873
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemodynamic effects of medical and surgical therapy of hypertrophic obstructive cardiomyopathy (author's transl)].
    Lösse B; Kuhn H; Krönert H; Rafflenbeul D; Kirschner P; Schulte HD; Loogen F
    Z Kardiol; 1980 Jul; 69(7):470-7. PubMed ID: 7192456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The course of hypertrophic cardiomyopathy with outflow obstruction in patients under treatment].
    Cserhalmi L; Szabóki F; Csukás I; Ilovszky Z; Huszár G
    Orv Hetil; 1987 Aug; 128(35):1815-23. PubMed ID: 3627783
    [No Abstract]   [Full Text] [Related]  

  • 20. Relief of sever left ventricular outflow obstruction in a case of hypertrophic obstructive cardiomyopathy treated with practolol.
    Gamal ME; Schasfoort GB; Schrijvers LC
    Br Heart J; 1975 Feb; 37(2):225-8. PubMed ID: 1168060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.